Reshma Kewalramani

Reshma Kewalramani

Chief Executive Officer at VERTEX PHARMACEUTICALS INCORPORATED

Net worth: 57 M $ as of 2024-03-30

51 year
Health Technology
Consumer Services
Health Services

Profile

Reshma Kewalramani is President, Chief Executive Officer & Director at Vertex Pharmaceuticals, Inc. In the past she was VP-Global Clinical Development & Nephrology at Amgen, Inc. She received a doctorate from Boston University School of Medicine.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-02-22 136,507 ( 0.05% ) 57 M $ 2024-03-30
2023-06-15 80,739 ( 0.00% ) 93 657 $ 2024-03-30

Reshma Kewalramani active positions

CompaniesPositionStart
VERTEX PHARMACEUTICALS INCORPORATED Chief Executive Officer 2020-03-31
GINKGO BIOWORKS HOLDINGS, INC. Director/Board Member 2021-09-15
Director/Board Member 2021-08-02
Director/Board Member -
Biomedical Sciences Careers Program, Inc. Director/Board Member -
Director/Board Member 2023-09-17
All active positions of Reshma Kewalramani

Former positions of Reshma Kewalramani

CompaniesPositionEnd
AMGEN INC. Corporate Officer/Principal 2016-12-31
GINO BIOW Director/Board Member -
Kidney Health Initiative Director/Board Member -
See the detail of Reshma Kewalramani's experience

Training of Reshma Kewalramani

Boston University Undergraduate Degree
Boston University School of Medicine Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Reshma Kewalramani's experience

Connections

100 +

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies3
AMGEN INC.

Health Technology

VERTEX PHARMACEUTICALS INCORPORATED

Health Technology

GINKGO BIOWORKS HOLDINGS, INC.

Health Services

Private companies6

Health Services

Biomedical Sciences Careers Program, Inc.

Commercial Services

Technology Services

Kidney Health Initiative

Finance

See company connections
  1. Stock Market
  2. Insiders
  3. Reshma Kewalramani